Table 3.
Clinical and laboratory data in HBoV-infected children, and in the two groups.
| Clinical Manifestations | Total (n = 165) | Group A (n = 69) | Group B (n = 96) | p-Value |
|---|---|---|---|---|
| Upper RTIs, n (%) | 48 (29.1) | 13 (18.8) | 35 (36.4) | 0.014 |
| Lower RTIs, n (%) | 84 (50.9) | 40 (57.9) | 44 (45.8) | 0.626 |
| Pneumonia, n (%) | 18 (11) | 9 (13) | 9 (9.3) | 0.456 |
| Bronchiolitis, n (%) | 25 (15.1) | 8 (11.6) | 17 (17.7) | 0.28 |
| Gastroenteritis, n (%) | 18 (10.9) | 8 (11.6) | 10 (10.4) | 0.8 |
| Seizure, n (%) | 9 (5.5) | 3 (4.3) | 6 (6.2) | 0.596 |
| Fever, n (%) | 112 (67.8) | 42 (60.8) | 70 (72.9) | 0.102 |
| Fever as unique sign, n (%) | 16 (9.7) | 6 (8.7) | 10 (10.4) | 0.713 |
| Laboratory data | Total (n = 121) | Group A (n = 48) | Group B (n = 73) | p-Value |
| Altered WBC, n (%) | 70 (57.8) | 29 (60) | 41(56) | 0.965 |
| WBC (cell/microL), median (IQR) | 12,320 (8900–15,780) |
12,670 (9162–15,850) |
11,500 (8535–15,305) |
0.375 |
| Increased CRP, n (%) | 76 (62.8) | 27(56) | 49(67) | 0.226 |
| CRP (mg/dL), median (IQR) | 1.87 (0.56–5.06) | 1.5 (0.4–5.0) | 1.9 (0.6–5.8) | 0.314 |
RTIs: respiratory tract infections; WBC: white blood cell, IQR: interquartile; CRP: C-reactive protein.